Hap Trading, LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	SELL	$98.98 - $115.74 $5.87 Million - $6.86 Million	-59,300 Reduced 5.53%	1,012,300 $117 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $103 Million - $120 Million	1,071,600 New	1,071,600 $110 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $11.9 Million - $21.7 Million	190,800 New	190,800 $277,000
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $55.8 Million - $62.1 Million	-647,600 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $703,934 - $935,704	-9,800 Reduced 1.49%	647,600 $2.24 Million

Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $42.7 Million - $53.7 Million	636,900 Added 3106.83%	657,400 $3.19 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $17.3 Million - $25 Million	-313,100 Reduced 93.85%	20,500 $248,000
Q2 2020 Aug 10, 2020	BUY	$30.2 - $56.98 $10.1 Million - $19 Million	333,600 New	333,600 $1.55 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.